arrow
M

Mohammad Hifz Ur Rahman

national university of science & technology, oman
H指数:54
被引数:11.9万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Global burden of vision impairment due to age-related macular degeneration, 1990–2021, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2021

1990—2021年与年龄相关性黄斑变性相关的视力损害全球负担,以及至2050年的预测:一项针对2021年全球疾病负担研究的系统分析

2025-06-250
OA
Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021

1990至2021 204个国家和地区以及811个地方的371疾病和伤害的全球发病率,患病率,残疾寿命 (YLDs),残疾调整寿命 (DALYs) 和健康预期寿命 (HALE): 全球疾病负担研究2021的系统分析

LANCET
IF88.5
2024-05-01285
OAAI
Global fertility in 204 countries and territories, 1950-2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021

1950至2021 204个国家和地区的全球生育率,预测到2100: 全球疾病负担研究2021的综合人口分析

LANCET
IF88.5
2024-05-0143
OAAI
Global, regional, and national incidence of six major immune-mediated inflammatory diseases: findings from the global burden of disease study 2019

六种主要免疫介导的炎性疾病的全球、地区和国家发病率: 全球疾病负担研究2019的结果

2023-10-0131
OAAI
Global, regional, and national burden of rheumatoid arthritis, 1990-2020, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021

1990—2020年全球、区域及国家层面的类风湿关节炎疾病负担,以及2050年预测:2021年全球疾病负担研究的系统性分析

2023-10-0172
OAAI
Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021

全球、区域和国家糖尿病负担1990年2021年,以及患病率2050年预测: 全球疾病负担研究的系统分析2021

LANCET
IF88.5
2023-07-01941
OAAI
Global burden of chronic respiratory diseases and risk factors, 1990-2019: an update from the Global Burden of Disease Study 2019

全球慢性呼吸系统疾病负担和危险因素,1990 2019: 来自全球疾病负担研究2019的更新

2023-05-01150
OAAI
Global investments in pandemic preparedness and COVID-19: development assistance and domestic spending on health between 1990 and 2026

对大流行病防范和新型冠状病毒肺炎的全球投资: 发展援助和卫生1990年和2026的国内支出

2023-03-01140
OAAI
Assessing performance of the Healthcare Access and Quality Index, overall and by select age groups, for 204 countries and territories, 1990-2019: a systematic analysis from the Global Burden of Disease Study 2019

1990至2019,对204个国家和地区的整体和选定年龄组的医疗保健获取和质量指数的评估: 来自全球疾病负担研究2019的系统分析

2022-12-0168
OAAI
Tracking development assistance for health and for COVID-19: a review of development assistance, government, out-of-pocket, and other private spending on health for 204 countries and territories, 1990-2050

追踪卫生和新型冠状病毒肺炎发展援助: 1990至2050 204个国家和地区的发展援助,政府,自费和其他私人卫生支出的审查

LANCET
IF88.5
2021-10-0180
OAAI
Global, regional, and national progress towards Sustainable Development Goal 3.2 for neonatal and child health: all-cause and cause-specific mortality findings from the Global Burden of Disease Study 2019

全球、区域和国家在实现新生儿和儿童健康可持续发展目标3.2方面的进展: 全球疾病负担研究2019的全因和特定原因死亡率

LANCET
IF88.5
2021-09-01232
OAAI
Global, regional, and national burden of bone fractures in 204 countries and territories, 1990-2019: a systematic analysis from the Global Burden of Disease Study 2019
2021-09-01431
OA
Predicting the environmental suitability for onchocerciasis in Africa as an aid to elimination planning

预测非洲盘尾丝虫病的环境适宜性,以帮助消除计划

2021-07-2811
OAAI
Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the Right to Sight: an analysis for the Global Burden of Disease Study

30年来盲和视力损害的原因2020年和趋势,以及与视力相关的可避免盲症的患病率2020: 视权: 全球疾病负担研究的分析

2021-02-011.7K
OAAI
Mapping geographical inequalities in oral rehydration therapy coverage in low-income and middle-income countries, 2000-17

2000-17低收入和中等收入国家口服补液疗法覆盖范围的地理不平等

2020-08-0122
OAAI